back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-10-30 16:20 Tx date 2019-10-30 |
$RQB
RavenQuest BioMed Inc. |
Ahrens-Townsend, Mark William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-30 16:19 Tx date 2019-10-30 |
$RQB
RavenQuest BioMed Inc. |
Ahrens-Townsend, Mark William
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-30 16:19 Tx date 2019-10-30 |
$RQB
RavenQuest BioMed Inc. |
Ahrens-Townsend, Mark William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
165,000 | ||
| Filed 2018-06-01 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
889,000 | |
| Filed 2018-03-27 Tx date 2018-03-27 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+20,000 vol $0.095 each |
1,294,500 | |
| Filed 2018-03-12 Tx date 2018-03-09 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,550
+74,000 vol $0.075 each |
1,274,500 | |
| Filed 2018-01-05 Tx date 2018-01-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,500
+100,000 vol $0.085 each |
1,200,500 | |
| Filed 2017-12-20 Tx date 2017-12-14 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50.00
+500 vol $0.10 each |
1,100,500 | |
| Filed 2017-08-17 Tx date 2017-08-17 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+250,000 vol |
500,000 | |
| Filed 2017-08-17 Tx date 2017-08-17 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+250,000 vol $0.12 each |
1,100,000 | |
| Filed 2017-08-01 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+160,000 vol $0.30 each |
689,000 | |
| Filed 2017-07-20 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$45,000
+250,000 vol $0.18 each |
250,000 | |
| Filed 2017-07-20 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+250,000 vol $0.12 each |
850,000 | |
| Filed 2017-07-20 Tx date 2015-05-11 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-13 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,400,000 vol |
600,000 | |
| Filed 2017-03-13 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,116,000 vol |
529,000 | |
| Filed 2016-11-14 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
57 - Exercise of rights
|
$-39,150
-1,305,000 vol $0.03 each |
0 | |
| Filed 2016-11-14 Tx date 2016-04-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
56 - Grant of rights
|
+1,305,000 vol |
||
| Filed 2016-11-14 Tx date 2016-04-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
56 - Grant of rights
|
$39,150
+1,305,000 vol $0.03 each |
1,305,000 | |
| Filed 2016-11-14 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
57 - Exercise of rights
|
-1,305,000 vol |
||
| Filed 2016-11-14 Tx date 2015-05-11 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-24 Tx date 2016-06-21 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,495,000 vol |
2,645,000 | |
| Filed 2016-05-04 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$50,850
+1,695,000 vol $0.03 each |
3,000,000 | |
| Filed 2016-02-16 Tx date 2016-02-16 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
1,305,000 | |
| Filed 2016-01-05 Tx date 2016-01-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,950
+39,000 vol $0.05 each |
1,285,000 | |
| Filed 2016-01-05 Tx date 2016-01-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$92,000
+1,150,000 vol $0.08 each |
1,150,000 | |
| Filed 2016-01-05 Tx date 2015-05-11 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-04 Tx date 2015-11-04 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+50,000 vol $0.065 each |
1,246,000 | |
| Filed 2015-10-05 Tx date 2015-10-02 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,840
+96,000 vol $0.04 each |
1,196,000 | |
| Filed 2015-07-24 Tx date 2015-07-24 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30.00
+1,000 vol $0.03 each |
1,001,000 | |
| Filed 2015-07-24 Tx date 2015-07-24 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,465
+99,000 vol $0.035 each |
1,100,000 | |
| Filed 2015-07-08 Tx date 2015-07-08 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+150,000 vol $0.04 each |
1,000,000 | |
| Filed 2015-06-26 Tx date 2015-06-26 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
850,000 | |
| Filed 2015-06-19 Tx date 2015-06-19 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+200,000 vol $0.04 each |
700,000 | |
| Filed 2015-06-10 Tx date 2015-05-11 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-10 Tx date 2015-06-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,220
+316,000 vol $0.045 each |
500,000 | |
| Filed 2015-06-10 Tx date 2015-06-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,360
+184,000 vol $0.04 each |
184,000 |